Equity Capital Markets

Company · CIK 1640266

Voyager Therapeutics, Inc.

CIK1640266 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressMA
ListedVYGR (Nasdaq)
First annual or quarterly report2015-12-17

Offerings

5 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-291418
ShelfEffective
 2025-11-102025-12-012
333-268240
ShelfEffective
 2022-11-082024-01-084
333-234527
ShelfEffective
 2019-11-062019-12-022
333-214861
ShelfEffective
 2016-12-012017-11-084
333-207367
IPOFinal prospectus
 2015-10-092015-11-127

Filings

20
FiledFilingRegistrationAccession
2025-12-01EFFECTDeclared effective 333-2914189999999995-25-003446
2025-11-10S-3Shelf registered 333-2914180001104659-25-109125
2024-01-08424B5Shelf takedown 333-2682400001104659-24-002229
2024-01-04424B5Shelf takedown 333-2682400001104659-24-001442
2022-11-15EFFECTDeclared effective 333-2682409999999995-22-003307
2022-11-08S-3Shelf registered 333-2682400001104659-22-115709
2019-12-02EFFECTDeclared effective 333-2345279999999995-19-002724
2019-11-06S-3Shelf registered 333-2345270001047469-19-006100
2017-11-08424B5Shelf takedown 333-2148610001047469-17-006885
2017-11-06424B5Shelf takedown 333-2148610001047469-17-006805
2016-12-20EFFECTDeclared effective 333-2148619999999995-16-006515
2016-12-01S-3Shelf registered 333-2148610001047469-16-017015
2015-11-12424B4Final prospectus 333-2073670001047469-15-008542
2015-11-10EFFECTDeclared effective 333-2073679999999995-15-003015
2015-11-06S-1/AAmendment 333-2073670001047469-15-008422
2015-11-04S-1/AAmendment 333-2073670001047469-15-008329
2015-10-30S-1/AAmendment 333-2073670001047469-15-008167
2015-10-28S-1/AAmendment 333-2073670001047469-15-008107
2015-10-09S-1Registration filed 333-2073670001047469-15-007779
2015-06-19DRSDraft made public 377-010440000912057-15-000165

All filings of this company · CSV